Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_assertion description "[The relative potency of interferon alpha (IFN alpha), interferon beta (IFN beta), and interferon gamma (IFN gamma) in inducing the expression of HLA class I antigens, as well as their capacity to counteract the inhibition induced by glucocorticoid hormones on HLA class I antigen expression, were analysed in the human melanoma cell line M14, both at membrane and at mRNA level.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_assertion evidence source_evidence_literature NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_assertion SIO_000772 7543821 NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_assertion wasDerivedFrom befree-2016 NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_assertion wasGeneratedBy ECO_0000203 NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.
- befree-2016 importedOn "2016-02-19" NP1311803.RACfBV1Qy8VA6ldojfRCmWymbP1ey8JxS7nrAlLGAHWYo130_provenance.